Showing 1711-1720 of 1735 results for "".
- Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in Acuvue Oasys Max 1-Day Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-reveals-new-data-on-blue-violet-light-filtering-technology-in-acuvue-oasys-max-1-day-contact-lenses/2481196/Johnson & Johnson Vision Care will present new data on the positive effects of wearing blue-violet light filtering contact lenses at the 2022 American Academy of Optometry (AAO) annual meeting in San Diego, October 26-29. "As a result of our increasingly digital
- NIH Study Confirms Benefit of Supplements for Slowing AMDhttps://modernod.com/news/nih-study-confirms-benefit-of-supplements-for-slowing-age-related-macular-degeneration-amd/2480894/The Age-Related Eye Disease Studies (AREDS and AREDS2) established that dietary supplements can slow progression of age-related macular degeneration (AMD), according to the Nationa
- Nicox Appoints Robert N. Weinreb, MD, and Sanjay G. Asrani, MD, to its Glaucoma Clinical Advisory Boardhttps://modernod.com/news/nicox-appoints-robert-n-weinreb-md-and-sanjay-g-asrani-md-to-its-glaucoma-clinical-advisory-board/2479362/Nicox SA announced that two internationally recognized experts in glaucoma, Robert N. Weinreb, MD, Distinguished Professor and Chair, Ophthalmology and Director, Shiley Eye Institute, University of California San Diego; and Sanjay G. Asrani, MD, Professor of Ophthalmology, Duke University, will b
- New COVID-19 Clinical Trial Supported by Octapharma USAhttps://modernod.com/news/new-covid-19-clinical-trial-supported-by-octapharma-usa/2477593/Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, MD, of Sharp Memorial Hospital in San Diego, focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing respiratory failure who become ventilator depen
- Acuity Eye Group Offers Tips During National Nutrition Month For Better Visionhttps://modernod.com/news/acuity-eye-group-offers-tips-during-national-nutrition-month-for-better-vision/2477373/More and more evidence is showing that diet has an impact on every aspect of ones health, including vision. In honor of National Nutrition Month, doctors at Acuity Eye Group have tips and recommendations to eat your way to better vision. Research shows that a healthy diet and lifestyle wit
- Novo Nordisk’s Rybelsus Gains FDA Approval as First Oral GLP-1 Receptor Agonist for Type 2 Diabeteshttps://modernod.com/news/novo-nordisks-rybelsus-gains-fda-approval-as-first-oral-glp-1-receptor-agonist-for-type-2-diabetes/2476907/The FDA announced Friday the approval of Novo Nordisk’s Rybelsus (semaglutide) to improve control of blood glucose in adults with type 2 diabetes, along with diet and exercise, making it the first oral GLP-1 receptor agonist cleared in the US. Lisa Yanoff, acting director of the Division of
- Registration Now Open for International Sports Vision Association Annual Conferencehttps://modernod.com/news/registration-now-open-for-international-sports-vision-association-annual-conference/2476869/Registration is now open for Beyond 20/20, the 4th annual International Sports Vision Association (ISVA) conference, February 6-8, 2020, at the Bahia Resort Hotel in San Diego, California. “Sports Vision, the science of helping athletes reach peak levels of performance through t
- Examining the Role of Vitamin B3 Supplementation in Reducing and Preventing Retinal Cell Damage Caused by Glaucomahttps://modernod.com/news/examining-the-role-of-vitamin-b3-supplementation-in-reducing-and-preventing-retinal-cell-damage-caused-by-glaucoma/2476813/UK-based Fight for Sight is funding researchers at Cardiff University to examine the extent to which dietary supplementation of Nicotinamide—a form of vitamin B3—can be used to reduce, and even prevent, retinal damage caused by glaucoma. This important research could help pave the way for new typ
- Harrow Health to Locate Headquarters in Nashville, Tennesseehttps://modernod.com/news/harrow-health-to-locate-headquarters-in-nashville-tennessee/2476667/Harrow Health announced that the company will relocate its headquarters from San Diego to Nashville, Tennessee. “From our new home in Nashville, our team will continue to start, finance and grow pharmaceutical companies that will develop innovative, affordable and accessible medicines to s
- Thomas Walters, MD, Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019https://modernod.com/news/thomas-walters-md-presents-update-on-nicoxs-ncx-470-phase-2-clinical-study-in-podium-presentation-at-ascrs-2019/2476555/Nicox SA announced that ophthalmology key opinion leader and clinical investigator in the ongoing NCX 470 phase 2 clinical study, Thomas Walters, MD, delivered a podium presentation at the annual ASCRS 2019 meeting in San Diego updating on the progress of the NCX 470 phase 2 clinical study in pat